{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:45Z","timestamp":1761581325081},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.juro.2015.05.104","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T22:03:48Z","timestamp":1436652228000},"page":"1214-1219","source":"Crossref","is-referenced-by-count":13,"title":["Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1097","volume":"194","author":[{"given":"Michael L.","family":"Blute","sequence":"first","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Rushmer","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jason","family":"Abel","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Jarrard","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy M.","family":"Downs","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"},{"name":"University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.05.104_bib1","first-page":"2381","article-title":"Expression of VEGF and its receptors VEGFR1\/VEGFR2 is associated with invasiveness of bladder cancer","volume":"33","author":"Kopparapu","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.juro.2015.05.104_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.urology.2013.01.027","article-title":"Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist","volume":"81","author":"Hansel","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.05.104_bib3","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.104_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","article-title":"The treated natural history of high risk superficial bladder cancer: 15-year outcome","volume":"158","author":"Cookson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.104_bib5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","article-title":"Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","volume":"164","author":"Mill\u00e1n-Rodr\u00edguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.104_bib6","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1245\/s10434-012-2568-z","article-title":"Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer","volume":"19","author":"Yuge","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.juro.2015.05.104_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1570161043385556","article-title":"Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer","volume":"2","author":"Escobar","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.juro.2015.05.104_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.juro.2015.05.104_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157488709788185996","article-title":"Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in urogenital cancer","volume":"4","author":"Miyajima","year":"2009","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.juro.2015.05.104_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis\u2014correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.05.104_bib11","first-page":"401","article-title":"Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma","volume":"143","author":"Weidner","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.juro.2015.05.104_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/jpet.102.034231","article-title":"Significance of vascular endothelial cell growth\u00a0factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas","volume":"302","author":"Katada","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.juro.2015.05.104_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(00)00350-2","article-title":"Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas","volume":"402","author":"Muramatsu","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.juro.2015.05.104_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0006-291X(02)00496-5","article-title":"Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis","volume":"294","author":"Fujita","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.juro.2015.05.104_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2014.09.019","article-title":"The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer","volume":"355","author":"Okazaki","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.juro.2015.05.104_bib16","article-title":"Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma","author":"Chen","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.juro.2015.05.104_bib17","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/1078-0432.CCR-04-1946","article-title":"Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination","volume":"11","author":"Suganuma","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2015.05.104_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-0774.2007.00025.x","article-title":"Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer","volume":"20","author":"Kosugi","year":"2007","journal-title":"Hum Cell"},{"key":"10.1016\/j.juro.2015.05.104_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.20486","article-title":"Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer","volume":"67","author":"Kosaka","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2015.05.104_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/bgn171","article-title":"The renin-angiotensin system and malignancy","volume":"29","author":"Ager","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.juro.2015.05.104_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s004180100313","article-title":"Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ\u00a0carcinoma but not in invasive carcinoma","volume":"116","author":"De Paepe","year":"2001","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.juro.2015.05.104_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MOU.0b013e328356adff","article-title":"Strategies to prevent progression of high-risk bladder cancer at initial diagnosis","volume":"22","author":"Ku","year":"2012","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2015.05.104_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.juro.2013.08.022","article-title":"The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin","volume":"191","author":"Sfakianos","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.104_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2011.565","article-title":"Prognostic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma","volume":"106","author":"Tanaka","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2015.05.104_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pros.21312","article-title":"Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells","volume":"71","author":"Hoshino","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2015.05.104_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1568009054629663","article-title":"Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer","volume":"5","author":"Uemura","year":"2005","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715043608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715043608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.05.104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:58:56Z","timestamp":1651204736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.05.104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1016\/j.juro.2015.05.104"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.05.104","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}